Paras Healthcare IPO
Paras Healthcare IPO on BSE, NSE. Opens 21 Oct 2026 and closes 23 Oct 2026. Price band ₹693. Lot size 21 shares. Allotment 26 Oct 2026.
Price Band
₹693
Bookbuilding IPO
Issue Size
₹1,450.00 Cr
Fresh: ₹500.00 Cr
Latest GMP
₹13(+1.88%)
Est. ₹706
IPO Timeline & Milestones
All dates anchored to Indian Standard Time (IST)
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 21 | ₹14,553 |
| Retail (Max) | 13 | 273 | ₹1,89,189 |
| S-HNI (Min) | 14 | 294 | ₹2,03,742 |
| S-HNI (Max) | 68 | 1428 | ₹9,89,604 |
| B-HNI (Min) | 69 | 1449 | ₹10,04,157 |
Grey Market Premium (GMP)
Positive Sentiment₹13(+1.88%)
Quote observed
Upper Price Band
₹693
Retail Lot Size
21 Shares
Min. Investment (1 Lot)
₹14,553
Est. Lot Value
₹14,826
Quick Lot & Listing Gain Simulator
Test multi-lot ASBA outlay and custom GMP scenarios for Paras Healthcare
Grey market quotes are unofficial, unregulated sentiment indicators and do not guarantee listing returns.
Historical GMP Trend
Chronological grey market premium movements
| Observation Date | GMP Premium | Daily Trend | Expected Listing | Recorded At |
|---|---|---|---|---|
| 21 Nov 2026 | ₹13(+1.88%) | 0 | ₹706 | 21 Nov 2026, 4:46 pm |
| 21 Nov 2026 | ₹13(+1.88%) | 0 | ₹706 | 21 Nov 2026, 3:50 am |
| 20 Nov 2026 | ₹13(+1.88%) | 0 | ₹706 | 20 Nov 2026, 2:10 pm |
| 20 Nov 2026 | ₹13(+1.88%) | 0 | ₹706 | 20 Nov 2026, 2:00 am |
| 19 Nov 2026 | ₹13(+1.88%) | 0 | ₹706 | 19 Nov 2026, 1:10 pm |
| 19 Nov 2026 | ₹13(+1.88%) | 0 | ₹706 | 19 Nov 2026, 1:00 am |
| 18 Nov 2026 | ₹13(+1.88%) | — | ₹706 | 18 Nov 2026, 12:04 pm |
Sector Benchmark · Pharmaceuticals & Healthcare
Historical Listing-Day Performance
Listing-day debut returns compared against issue price across healthcare peers.
Sector Avg. Gain
+16.7%
Across 6 sector peers
Median Debut
+19.4%
Typical listing return
Positive Debuts
6/6
100% listed above issue
Top Sector Debut
+31.4%
Emcure Pharmaceuticals
| Company | Cohort | Issue Price | Listing Price | Listing Gain |
|---|---|---|---|---|
Paras HealthcareCurrent | 2026 · Mainboard | ₹693 | ₹706 | +1.9% |
Emcure Pharmaceuticals | 2024 · Mainboard | ₹1,008 | ₹1,325 | +31.4% |
Concord Biotech | 2023 · Mainboard | ₹741 | ₹900 | +21.5% |
Mankind Pharma | 2023 · Mainboard | ₹1,080 | ₹1,300 | +20.4% |
Sai Life Sciences | 2024 · Mainboard | ₹549 | ₹650 | +18.4% |
Akums Drugs & Pharma | 2024 · Mainboard | ₹679 | ₹725 | +6.8% |
Yatharth Hospital | 2023 · Mainboard | ₹300 | ₹306 | +2% |
Historical NSE/BSE Pharmaceuticals & Healthcare IPO listing-day benchmarks versus issue price. Historical listing-day gains are shown for educational sector context only and do not guarantee future listing performance.
Paras Healthcare IPO Financials
Restated Consolidated
Paras Healthcare Ltd.'s revenue increased by 24% and profit after tax (PAT) rose by 176% between the financial year ending with March 31, 2026 and March 31, 2025.
| Period Ended | 30 Jun 2026 | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|---|
| Assets | 2,202.88 | 2,071.14 | 1,810.45 | 1,477.66 |
| Total Income | 478.75 | 1,628.78 | 1,314.21 | 1,151.02 |
| Profit After Tax | 49.68 | 43.83 | -57.98 | -15.33 |
| EBITDA | 113.48 | 335.58 | 156.46 | 154.41 |
| NET Worth | 444.96 | 394.94 | 280.49 | 338.51 |
| Reserves and Surplus | 434.86 | 384.84 | 270.73 | 328.75 |
| Total Borrowing | 1,429.49 | 1,393.86 | 1,232.12 | 923.92 |
Amount in ₹ Crore
Financial Highlights
Key performance metrics from audited statements
Revenue
₹1,628.78 Cr
Profit After Tax (PAT)
₹43.83 Cr
Fresh Issue
₹500.00 Cr
Offer for Sale (OFS)
₹950.00 Cr
Shareholding Structure
| Category | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 72.80% | 63.95% |
| Public | 27.20% | 36.05% |
| Total | 100% | 100% |
About Paras Healthcare
Company overview and operations summary
Explore Other Mainboard IPOs
Compare issue dates, price bands, and sentiment with other active public issues.